Pfizer

Global Psychedelic Drugs Market Expected To Reach $10.2B By 2028 Amid Growing Mental Health Crises
Cathie Wood's Ark Invest Dumps Over $9M In Moderna Stock — Even With Post-COVID Plans On The Table
Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration
Cathie Wood's Ark Invest Dumps Over $9M In Moderna Stock — Even With Post-COVID Plans On The Table
Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration
Pfizer Initiates Multi-Year Cost Reduction Plan Targeting $1.5B Savings By 2027
16-Minute Gene Therapy Restores Hearing To British Baby, A World First

Pfizer Recent News

Pfizer Agrees To Pay $93M To Settle Lipitor Antitrust Lawsuit Despite Calling Allegations 'Factually And Legally Without Merit'
Pfizer has agreed to pay $93 million to settle an antitrust lawsuit related to its cholesterol drug Lipitor.
Costco, Pfizer, Moderna, Lennar Corp, Tesla: Why These 5 Stocks Are On Investors' Radars Today
The stock market witnessed a notable surge today, with the Dow Jones rising 0.43% to 37,248.35 and the S&P 500 gaining 0.26% to 4,719.55.
Apple, Adobe, Pfizer, Alibaba, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Major U.S. indices were in the green on Wednesday with the Dow Jones rising 1.4% to 37,090.24, the S&P 500 gaining 1.37% to 4,707.09.
Voicing Opinions On Israel-Hamas Conflict: A Double-edged Sword For Businesses
According to an Associated Press report, the Israel-Hamas conflict has stirred up controversy within the global business sector.
Tesla, Oracle, Novavax, DraftKings, Pfizer: Why These Five Stocks Are Trending Today
U.S. stocks showcased a positive momentum as the trading day approached its end. The Nasdaq Composite exhibited a notable rise, gaining more than 1% on Monday.
GameStop, Apple, Pfizer, Tesla, AMC: Why These 5 Stocks Are Trending Today
Cannabis Industry's Capital Crunch: Why It Needs More Funds Than Other Industries, Will Fed Legalization Change This?
Recent research conducted by Viridian Capital Advisors reveals that the cannabis sector requires more capital as compared to other similar industries.
European Regulator Expands Ozempic Probe To Include Other Weight Loss Drugs Over Suicide Risks
Zoetis Declares New Dividend, Hinting At Undervaluation
Zoetis (NYSE: ZTS) shareholders may have a new reference point to be excited about, even after witnessing some favorable developments through the company's first quarter 2023 announcements.
Recently Revealed Pfizer Collaboration Might Just Be What The Doctor Ordered For TFF Pharmaceuticals
By StoryTrading Pfizer collaboration just revealed in presentation update - no PR issued yet! – Several near-term catalysts possible, including further partnerships with big pharma – Sentiment: CEO’s credibility hit from under-delivering now turning around 
Benzinga's Bulls And Bears Of The Week: Coinbase, Netflix, PayPal, Pfizer, Tesla And More
Benzinga has examined the prospects for many investor favorite stocks over the past week. Last week's bullish calls included a FAANG stock and a COVID-19 vaccine maker.
Boosters And Mandate Could Increase Vaccine Demand
This is an excerpt from Medically Necessary, a health care supply chain newsletter. Subscribe here.
Sponsored
This Cancer Screening Company Has A Better 5-Year Return Than Pfizer, Johnson & Johnson And Gilead
Small-cap stocks have a history of outperforming large-cap names as they have the potential for rapid growth and have event-driven moves for share prices. A company focused on cancer screening and diagnostic tests has outperformed some of the largest healthcare companies over the last five years and went from small-cap to a market cap of more than $18 billion.
Moderna Boosters Might Not Be Ready By Sept 20, Pfizer On Track: Fauci
On Sunday, President Joe Biden's Chief Medical Adviser Dr. Anthony Fauci said officials would soon get the regulatory clearance to administer Covid-19 vaccine booster shots made by Pfizer Inc (NYSE: PFE).
Wana Brands, Medicine Man Dispensaries, Colorado Health Authorities Team Up On COVID-19 Vaccination Clinics
Wana Brands, the pioneering edibles manufacturer, is partnering with Medicine Man dispensaries along with the Colorado Dept.
Airbnb Did Not Deliver Vaccines- But It Is Just As Much Of A Hero
Last week, Reuters reported that Airbnb (NASDAQ: ABNB) has offered to provide free, temporary housing to 20,000 Afghan refugees across the globe, helping its shares close up 10% after the announcement.
Sponsored
Benzinga's Bulls And Bears Of The Past Week: Alibaba, Bitcoin, Pfizer, Tesla And More
Benzinga has examined the prospects for many investor favorite stocks over the past week. Last week's bullish calls included a top COVID-19 vaccine play, a recent high-profile IPO and a trendy retailer.
Strong Crude, Higher Yields, Best Buy Earnings Combine To Give Market Early Lift
After another big rally to start the week, what can Wall Street do for an encore?  Maybe not a lot, at least for the moment. Stocks moved up just a bit in pre-market trading. It looks early like there might be a chance for small gains on top of what happened yesterday, but a lack of major new developments may keep things on a simmer. 
Sponsored
Tuesday's Market Minute: Markets Rally On FDA Vaccine Approval
Investors may be scratching their heads at the resiliency shown by the major U.S. stock indices as of late. Despite the Delta variant unleashing renewed fears of economic shutdowns globally and other factors that should be dampening markets – supply chain issues, labor and semiconductor shortages, inflation – stocks remain at all-time-highs.
Sponsored
BioMedNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Receives FDA Clearance For mmRNA Oral Appliance
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.
Sponsored
The Latest Barron's Picks And Pans: Facebook, Jefferies, Palantir, Spotify And More
This weekend's Barron's cover story examines the long-term prospects for big tech companies currently in the sights of regulators and lawmakers.
Benzinga's Bulls And Bears Of The Week: Apple, Coinbase, Starbucks, Virgin Galactic, Walmart And More
Benzinga has examined the prospects for many investor favorite stocks over the past week. Last week's bullish calls included top growth and reopening stocks. Automakers and a leading cryptocurrency play were among the bearish calls seen.
Moderna's Shot Seems To Have A Better Shot Against Delta Than Pfizer's
Besides proudly stating that its Covid-19 shot produced a "robust" antibody response against the highly contagious delta variant last Thursday, Moderna (NASDAQ: MRNA) also posted second-quarter financial results that beat Wall Street's expectations on both earnings and revenue.
Sponsored

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved